Description

The Human CD28 / CD86 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between T-lymphocyte activation antigen CD86 and its receptor T-cell-specific surface glycoprotein CD28 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.